Pay in 4 interest-free payments of $6.48 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
60 This extensive resource supports healthcare providers and patients in making informed choices about biologic substitutions, intending to foster market competition and reduce healthcare costs for expensive biological therapies, which have historically lacked generic alternatives
Appeal outcomes are not guaranteed and depend on your specific plan and documentation
doi:10.1016/j.envres.2013.07.005
Patients meeting the following criteria were excluded from the analysis: evidence of type 1 diabetes or pregnancy in the study period, missing age or sex data, initiation of another new glucose-lowering therapy on the index date, and use of any GLP-1RA in the baseline period
$65.00 is a value for the money when you compare something like this that works with a ton of other similar things on the market that are hit or miss
